Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib
Author:
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference181 articles.
1. Signaling by ABL oncogenes through cyclin D1.
2. CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall
3. Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids
4. Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate
Cited by 286 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Decoding the Mystery of Blood Cancer: Cause, Diagnosis, and Management;Current Cancer Therapy Reviews;2025-01
2. Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway;Cancer Cell International;2024-05-29
3. Current Progress on the Influence Human Genetics Has on the Efficacy of Tyrosine Kinase Inhibitors Used to Treat Chronic Myeloid Leukemia;Cureus;2024-03-20
4. Evaluation the Anti-leukemia effect of Methanol extracts of Camellia cuongiana on the K562 cell line;Research Journal of Pharmacy and Technology;2024-02-20
5. New Derivatives of 1-(3-Methyl-1-Benzofuran-2-yl)Ethan-1-one: Synthesis and Preliminary Studies of Biological Activity;International Journal of Molecular Sciences;2024-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3